Reuters reveals EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags

Reuters reported exclusively that European efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method and potential liability costs. The bloc is in talks with at least six vaccine makers to acquire up front doses of potential shots against the novel coronavirus, a strategy meant to increase the chances of having COVID-19 vaccines for its population.

Article Tags
Topics of Interest: DealsHealth
Type: Reuters Best
Sectors: Equities
Regions: Europe
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Sign up for email updates

Sign up for email updates